Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature ; volume:8 ; number:1 ; day:11 ; month:6 ; year:2018 ; pages:1-11 ; date:12.2018
Scientific reports ; 8, Heft 1 (11.6.2018), 1-11, 12.2018
- Classification
-
Naturwissenschaften
- Creator
-
Chang, Yoosup
- Contributor
-
Park, Hyejin
Yang, Hyun-Jin
Lee, Seungju
Lee, Kwee-Yum
Kim, Tae Soon
Jung, Jongsun
Shin, Jae-Min
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-27214-6
- URN
-
urn:nbn:de:101:1-2018081120573895282548
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chang, Yoosup
- Park, Hyejin
- Yang, Hyun-Jin
- Lee, Seungju
- Lee, Kwee-Yum
- Kim, Tae Soon
- Jung, Jongsun
- Shin, Jae-Min
- SpringerLink (Online service)
Other Objects (12)
Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer
In silico modeling predicts drug sensitivity of patient-derived cancer cells
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
Disulfidptosis signature predicts immune microenvironment and prognosis of gastric cancer
Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer
Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy
Drug repurposing for cancer therapy
Single-cell transcriptional signature-based drug repurposing and in vitro evaluation in colorectal cancer
Transcriptomic signature for drug-induced steatosis
Alkylphosphocholines: new drugs in cancer therapy
Drug delivery in cancer treatment, [1].
Drug delivery methods for cancer immunotherapy
Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer
In silico modeling predicts drug sensitivity of patient-derived cancer cells
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
Disulfidptosis signature predicts immune microenvironment and prognosis of gastric cancer
Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer
Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy
Drug repurposing for cancer therapy
Single-cell transcriptional signature-based drug repurposing and in vitro evaluation in colorectal cancer
Transcriptomic signature for drug-induced steatosis
Alkylphosphocholines: new drugs in cancer therapy
Drug delivery in cancer treatment, [1].
Drug delivery methods for cancer immunotherapy
Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer
In silico modeling predicts drug sensitivity of patient-derived cancer cells
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
Disulfidptosis signature predicts immune microenvironment and prognosis of gastric cancer
Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer
Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy
Drug repurposing for cancer therapy
Single-cell transcriptional signature-based drug repurposing and in vitro evaluation in colorectal cancer
Transcriptomic signature for drug-induced steatosis
Alkylphosphocholines: new drugs in cancer therapy
Drug delivery in cancer treatment, [1].